| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 06/10/2010 | US20100143887 Biosensor and method for detecting biomolecules by using the biosensor |
| 06/10/2010 | US20100143886 In vivo hcv resistance to anti-viral inhibitors |
| 06/10/2010 | US20100143885 Detection of human papillomavirus |
| 06/10/2010 | US20100143884 Detection of influenza virus |
| 06/10/2010 | US20100143883 Capture of mycobacteria like micro-organisms |
| 06/10/2010 | US20100143882 Improved multiplex nucleic acid amplification using blocked primers |
| 06/10/2010 | US20100143881 Selective detection of human rhinovirus |
| 06/10/2010 | US20100143880 Analysis method for determining a functional parameter of an organ using preferably an aqueous 13c-methacetin solution |
| 06/10/2010 | US20100143500 Methods and Compositions for Inhibiting GSK-3 In Glial Cell Related Disorders |
| 06/10/2010 | US20100143415 Streptococcus Pneumoniae Antigens |
| 06/10/2010 | US20100143411 Method for identification of t-lymphocyte antigens |
| 06/10/2010 | US20100143409 Generation of virus-like particles and use as panfilovirus vaccines |
| 06/10/2010 | US20100143407 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences |
| 06/10/2010 | US20100143383 Oxgr1 agonists for use in therapies for metabolic disorders |
| 06/10/2010 | US20100143381 Lysophosphatidic acid receptor targeting for lung disease |
| 06/10/2010 | US20100143379 Mif agonists and antagonist and therapeutic uses thereof |
| 06/10/2010 | US20100143376 Antibodies Specific for Rubella Virus |
| 06/10/2010 | US20100143372 Interferon alpha-induced pharmacodynamic markers |
| 06/10/2010 | US20100143361 Methods for the treatment of a-beta related disorders and compositions therefor |
| 06/10/2010 | US20100143360 Human vascular endothelial growth factor 2 |
| 06/10/2010 | US20100143359 Expression of foxp3 by cancer cells |
| 06/10/2010 | US20100143347 Targeting ncca-atp channel for organ protection following ischemic episode |
| 06/10/2010 | US20100143339 Methods of treating and preventing colitis involving il-13 and nk-t cells |
| 06/10/2010 | US20100143337 Compositions and methods for characterizing and regulating olfactory sensation |
| 06/10/2010 | US20100143330 Methods of treating disorders associated with fat storage |
| 06/10/2010 | US20100143318 Gstp1 as teratogenic allele for autism and assays and methods based thereon |
| 06/10/2010 | US20100143261 Composition for the diagnosis, prevention or treatment of diseases related to cells expressing il-8 or gro-alpha, comprising ucb-mscs |
| 06/10/2010 | US20100143259 Fluorescent microspheres, the preparation method and uses thereof |
| 06/10/2010 | US20100143255 Fig4 gene mutations in neurodegeneration |
| 06/10/2010 | US20100143251 Compounds and amyloid probes thereof for therapeutic and imaging uses |
| 06/10/2010 | US20100143247 Diagnosis of prostate cancer |
| 06/10/2010 | US20100141947 Small Angle Light Scattering System and Method for Detecting Changes in Cell Parts |
| 06/10/2010 | US20100140087 Biosensor, biosensor chip and biosensor device |
| 06/10/2010 | US20100140086 Methods and apparatus for improved luminescence assays using microparticles |
| 06/10/2010 | DE102009026814A1 Nanopartikel zum Nachweisen von Biomaterialien und Biosensor unter Verwendung des Nanopartikels Nanoparticles for the detection of biomaterials and biosensor using the nanoparticle |
| 06/10/2010 | DE102008061174A1 Assigning biological sample to donor of sample, comprises obtaining DNA sample, determining DNA sequences of non-coding regions, obtaining biological sample, isolating DNA-containing cells, determining and comparing DNA sequences |
| 06/10/2010 | DE102006024058B4 Modulares System mit immobilisierten Nukleinsäuren und/oder Nukleinsäurederivaten an metallischen Oberflächen und Verfahren zu dessen Herstelung Modular system with immobilized nucleic acids and / or nucleic acid derivatives to metallic surfaces and method of Herstelung |
| 06/10/2010 | CA2782188A1 Method for detection of autoimmune diseases |
| 06/10/2010 | CA2749570A1 Chromatin structure detection |
| 06/10/2010 | CA2748712A1 Methods of determining efficacy of glucocorticoid treatment of eosinophilic esophagitis |
| 06/10/2010 | CA2746003A1 Treatment of vascular endothelial growth factor (vegf) related diseases by inhibition of natural antisense transcript to vegf |
| 06/10/2010 | CA2746001A1 Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirtuin 1 |
| 06/10/2010 | CA2745961A1 Materials and methods for determining diagnosis and prognosis of prostate cancer |
| 06/10/2010 | CA2745811A1 Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the gene |
| 06/10/2010 | CA2745805A1 Methods of measuring adamts13-mediated in vivo cleavage of von willebrand factor and uses thereof |
| 06/10/2010 | CA2745781A1 Universal biological sample processing |
| 06/10/2010 | CA2745746A1 Microrna-based methods and compositions for the diagnosis and treatment of ovarian cancer |
| 06/10/2010 | CA2745576A1 Cytokines as prognostic markers of respiratory-tract infection following major surgery |
| 06/10/2010 | CA2745448A1 Methods for selecting protease resistant polypeptides |
| 06/10/2010 | CA2745430A1 Method of stratifying breast cancer patients based on gene expression |
| 06/10/2010 | CA2745329A1 Treatment of erythropoietin (epo) related diseases by inhibition of natural antisense transcript to epo |
| 06/10/2010 | CA2745280A1 Phosphatidylinositol-3-kinase p110 delta-targeted drugs in the treatment of cns disorders |
| 06/10/2010 | CA2744894A1 Real-time pcr through gigahertz or terahertz spectrometry |
| 06/10/2010 | CA2743736A1 Screening assays for the identification of bace2 inhibitors |
| 06/10/2010 | CA2742754A1 System and method for detection of hiv integrase variants |
| 06/10/2010 | CA2742678A1 Lateral flow strip assay with immobilized conjugate |
| 06/09/2010 | EP2194383A1 Monitoring immunologic, hematologic and inflammatory diseases |
| 06/09/2010 | EP2194379A1 Apparatus and methods for providing sex-sorted animal sperm |
| 06/09/2010 | EP2194147A1 Multiplex amplification of polynucleotides |
| 06/09/2010 | EP2194146A1 A molecular beacon and a method for its synthesis |
| 06/09/2010 | EP2194145A1 Diagnosing and monitoring transplant rejection based on marker expression levels |
| 06/09/2010 | EP2194143A2 Phenotype prediction |
| 06/09/2010 | EP2194142A1 Method of measuring cholesterol in high density lipoproteins |
| 06/09/2010 | EP2194141A1 Method of predicting drug-induced phospholipidosis |
| 06/09/2010 | EP2194133A2 Amylases, nucleic acids encoding them and methods for making and using them |
| 06/09/2010 | EP2194131A2 Cyclin-dependent kinase inhibitors and uses thereof |
| 06/09/2010 | EP2194130A1 Cytokine ZCYTO18 |
| 06/09/2010 | EP2194128A1 Compositions and methods for inhibiting expression of the PCSK9 gene |
| 06/09/2010 | EP2194123A1 DNA polymerase fusions and uses thereof |
| 06/09/2010 | EP2193377A2 Method of screening for compounds that can be used for the treatment of respiratory conditions |
| 06/09/2010 | EP2193370A2 Methods of screening for compounds having anti-inflammatory activity |
| 06/09/2010 | EP2193211A1 Identification of novel pathways for drug development for lung disease |
| 06/09/2010 | EP2193210A2 Method for the analysis of ovarian cancer disorders |
| 06/09/2010 | EP2193208A1 A method of dna amplification |
| 06/09/2010 | EP2193207A2 Stabilization of nucleic acids on solid supports |
| 06/09/2010 | EP2193206A1 Application of surface plasmon resonance technology for detecting and genotyping hpv |
| 06/09/2010 | EP1954829B1 Polynucleotide amplification |
| 06/09/2010 | EP1831402B1 Genetic variants of vkorc1 predicting warfarin sensitivity |
| 06/09/2010 | EP1745148B1 A method for identifying activators of gene transcription |
| 06/09/2010 | EP1702381B1 Suspension for the generation of a current of electrons and the use and the preparation thereof |
| 06/09/2010 | EP1587957B1 Gene expression markers for breast cancer prognosis |
| 06/09/2010 | EP1552010B1 Strategies for gene expression analysis |
| 06/09/2010 | EP1428018B1 Rapid and sensitive detection of molecules |
| 06/09/2010 | EP1411117B1 NASBA based method for detecting mycobacterium tuberculosis |
| 06/09/2010 | EP1335981B1 18480 human protein kinase molecules and uses therefor |
| 06/09/2010 | EP1062226B1 High affinity nucleic acid ligands of the complement system c5 protein |
| 06/09/2010 | EP1011686B1 Modulation of human mast cell activation |
| 06/09/2010 | CN201503436U Movable type quick inspection vehicle for animal disease |
| 06/09/2010 | CN201503433U Microorganism culture gas production detector |
| 06/09/2010 | CN201503402U Thermal infrared image diagnosis system for sclerotinia rot of colza |
| 06/09/2010 | CN201501881U Hypertension individuation pharmacotherapy genotype detecting chip and assorted reagent kit |
| 06/09/2010 | CN201501880U Fast detecting tube for pesticide residue |
| 06/09/2010 | CN201500106U Electric field generating device for rapidly pacemaking myocardial cells |
| 06/09/2010 | CN1982324B Oncogene, recombinant protein derived therefrom, and uses thereof |
| 06/09/2010 | CN1981043B Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine |
| 06/09/2010 | CN1932040B Automatic fast detection system for family members of whole genome target gene |
| 06/09/2010 | CN1922324B Bacterial virulence factors and uses thereof |
| 06/09/2010 | CN1645121B Quick determining method for period of pasteruzied milk on shelf |
| 06/09/2010 | CN1637153B Detection reagent for thermostable direct hemolysin gene of vibrio parahaemolyticus |
| 06/09/2010 | CN1630863B Method for crystallizing human GSK3 and novel crystal structure thereof |